Table 1 Chi-squared test on patient’s demographics
Demographics | All patients (n = 327) Mean (SD)/n (%) | Patients without adverse outcome (n = 277) Mean (SD)/n (%) | Patient with adverse outcome (n = 50) Mean (SD)/n (%) | P-value |
|---|---|---|---|---|
Age (y) | 75 (15) | 75 (16) | 74 (12) | 0.74 |
Gender | ||||
Male | 175 (54%) | 145 (52%) | 30 (60%) | 0.32 |
Female | 152 (46%) | 132 (48%) | 20 (40%) | 0.32 |
Co-morbidity | ||||
Coronary artery disease/ congestive heart failure | 139 (43%) | 112 (40%) | 27 (54%) | 0.07 |
Hypertension | 102 (31%) | 88 (32%) | 14 (28%) | 0.60 |
History of infectionsa | 83 (25%) | 72 (26%) | 11 (22%) | 0.55 |
Diabetes mellitus | 73 (22%) | 58 (21%) | 15 (30%) | 0.16 |
VChronic obstructive pulmonary disease | 56 (17%) | 44 (16%) | 12 (24%) | 0.16 |
Malignancy | 49 (15%) | 45 (16%) | 4 (8%) | 0.13 |
Cerebrovascular disease/ stroke | 48 (15%) | 42 (15%) | 7 (14%) | 0.83 |
Immunosuppress | 32 (10%) | 29 (11%) | 3 (6%) | 0.33 |
No co-morbidity | 23 (7%) | 21 (8%) | 2 (4%) | 0.36 |
Asthma | 14 (4%) | 14 (5%) | 0 (0%) | 0.10 |
Epilepsy | 5 (2%) | 4 (1%) | 1 (2%) | 0.77 |